Hydroxychloroquine Therapy in Massive Total Doses Without Retinal Toxicity
Authors:
- Mark W. JohnsonMJMark W. Johnson
- Andrew K. VineAVAndrew K. Vine
- 1 August 1987
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 104 (2) , 139-144
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The Effects of Chloroquine on Serum 1,25-Dihydroxyvitamin D and Calcium Metabolism in SarcoidosisNew England Journal of Medicine, 1986
- Dose refinements in long-term therapy of rheumatoid arthritis with antimalarialsThe American Journal of Medicine, 1983
- Ophthalmologic safety of long-term hydroxychloroquine sulfate treatmentThe American Journal of Medicine, 1983
- Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapyThe American Journal of Medicine, 1983
- IS CHLOROQUINE OBSOLETE IN TREATMENT OF RHEUMATIC DISEASE?The Lancet, 1979
- Ocular Changes Induced by Long-Term Hydroxychloroquine (Plaquenil) TherapyAmerican Journal of Ophthalmology, 1967
- INCIDENCE OF CHLOROQUINE RETINOPATHYActa Ophthalmologica, 1966
- Chloroquine RetinopathyArchives of Ophthalmology (1950), 1966
- Antimalarial therapy and early retinal changes in patients with rheumatoid arthritis.BMJ, 1966
- RETINOPATHY FOLLOWING CHLOROQUINE THERAPYThe Lancet, 1959